Home > Insider Trading > Filing (0001179110-22-000401)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1070081	Ptc Therapeutics Inc.	PTCT	Pharmaceutical Preparations (2834)	043416587

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1707685	Marie Christine Utter	C/O Ptc Therapeutics, Inc. 100 Corporate Court South Plainfield NJ 07080	Svp, Finance & Cao	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2022-01-07	747	$38.53	16,253	No	4	S	Direct
Common Stock	Acquisiton	2022-01-07	11,600	$0.00	27,853	No	4	A	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	A	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Acquisiton	2022-01-07	43,500	$0.00	43,500	$38.10

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
43,500		2032-01-06	No	4	A	Direct

Footnotes

Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 2,175 RSUs from a January 6, 2021 grant of 8,700 RSUs.
Includes 206 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ending June 30, 2021 and 285 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ending December 31, 2021.
Restricted stock units granted on January 7, 2022 that vest in four equal installments over four years, commencing on January 7, 2023.
This option was granted on January 7, 2022, and vests over four years, with 25% of the shares underlying the option vesting on January 7, 2023, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 7, 2023.